The Company is a Korea-based company mainly engaged in the research and development, manufacture and distribution of bio pharmaceuticals for animals using gene therapy. The Company provides small animal personalized medicines, infectious vaccines, growth hormone releasing hormone (GHRH), telomerase reverse transcriptase (TERT) and others. The Company's products are mainly used for pigs, cats, dogs, cows, horses and other animals. The Company was founded on January 2, 2014 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on July 28, 2015.
Headquarters
807,7,Heolleung-Ro, Seocho-Gu
Seoul; Seoul;
Contact Details: Purchase the Plumbline Life Sciences Inc. report to view the information.
Website: http://www.plumblinels.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service